Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Clinical trial NCT06779929 · COMPLETED
Trial details
- NCT number
- NCT06779929
- Sponsor
- Brigham and Women's Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 70000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.